LBPH - Nilai pasar Longboard Pharmaceuticals Inc

The share price retrospective for Longboard Pharmaceuticals (LBPH) reflects the dynamics of a company that fully outsources production and testing to third-party contractors, creating a high dependency on partners. The current metric stands at . The project is currently developing a network of epilepsy treatments, raising capital amid FDA approvals. The business specializes in creating high-precision molecules for the therapy of rare brain pathologies.

Longboard Pharmaceuticals, Inc. - Nilai pasar LBPH (periode 23.10.2026 - 23.10.2026)

LBPH (Longboard): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Longboard Pharmaceuticals (LBPH):

Rega saham Longboard Pharmaceuticals, Inc.|LBPH - Bagan rega target|Nilai pasar Longboard

Analisis fundamental perusahaan:LBPH (Longboard Pharmaceuticals, Inc.)

Sampel barang longboardpharma.com

The assessment of the financial stability of Longboard Pharmaceuticals begins with an analysis of its market scale. This indicator is calculated as the product of the current share price and the total number of issued securities. The dynamics of the company's market value reflect current capital inflows and market confidence in the asset. For Longboard Pharmaceuticals (LBPH), the capitalization confirms the investment attractiveness of implementing AI and bioanalysis automation. The growth of this metric signals success in accelerating the development of drugs for neuropsychiatric disorders.

Pesaing wigati

Kapitalisasi pasar BIIB (Biogen)|Neurocrine - Nilai pasar|RGC - Nilai pasar|Biji pasar AXSM|ACAD: Kapitalisasi pasar|xenon-pharma.com - Nilai pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|Nilai pasar PRTA|Nilai pasar Alector, Inc. (ALEC)|ANNX - Nilai pasar|Nilai pasar Omeros OMER|NGNE: Kapitalisasi pasar|AC Immune - Kapitalisasi pasar|Kapitalisasi pasar voyagertherapeutics.com (VYGR)|NMRA: Kapitalisasi pasar|SCLX (Scilex Holding) - Nilai pasar|Nilai pasar Tevogen Bio Holdings, Inc.|Nilai pasar Alpha Cognition Corp ACOG|Kapitalisasi pasar CGTX|Kapitalisasi pasar inhibikase.com (IKT)|Nilai pasar Cassava Sciences SAVA|Nilai pasar ASRT|Coya - Kapitalisasi pasar|VTGN (Vistagen Therapeutics) - Kapitalisasi pasar|OVID (ovidrx.com) - Biji pasar|acumenpharm.com - Nilai pasar|Nilai pasar CervoMed|Alterity Therapeutics Ltd - Biji pasar|Kapitalisasi pasar CLNN|PEPG (pepgen.com) - Nilai pasar|Kapitalisasi pasar JUNS (Jupiter Neurosciences)|Kapitalisasi pasar relmada.com RLMD|ANVS - Nilai pasar|Nilai pasar GRCE (Grace Therapeutics, Inc.)|Firefly Neuroscience Inc (AIFF) - Nilai pasar|Biji pasar Klotho Neurosciences|NRSN (NeuroSense Therapeutics Ltd) - Kapitalisasi pasar|Kapitalisasi pasar revivapharma.com|Kapitalisasi pasar MTVA|Biji pasar NeurAxis Inc. NRXS|Kapitalisasi pasar HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Nilai pasar|NEUP: Biji pasar|NERV - Kapitalisasi pasar|ATHA (Athira Pharma) - Biji pasar|ADXN: Nilai pasar|ALZN (Alzamend Neuro Inc.) - Kapitalisasi pasar|Cyclerion (CYCN) - Kapitalisasi pasar|Kapitalisasi pasar PTIX|Biji pasar pasitheaclinics.com KTTA|Kapitalisasi pasar CRGT (Cortigent)|Kapitalisasi pasar Avenue Therapeutics Inc. ATXI|BCLI - Nilai pasar|CARA: Nilai pasar|Chromocell Therapeutics (CHRO) - Nilai pasar|ELYM - Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies Inc.|Nilai pasar MRNS|Kapitalisasi pasar NKGN|Nilai pasar NRBO (NeuroBo Pharma)|Nilai pasar Sage Therapeutics, Inc. SAGE|SNPX (synaptogen.com) - Biji pasar|Trevena - Kapitalisasi pasar|Nilai pasar VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Nilai pasar|Kapitalisasi pasar CERE